Literature DB >> 26609297

Hand Foot Syndrome Secondary to Low Dose Docetaxel.

Mutahir A Tunio1, Mushabbab AlAsiri2, Sajid Khan Durrani3.   

Abstract

Hand-foot syndrome (palmoplantar erythrodysesthesia or Burgdorf reaction), is a distinctive skin toxicity affecting the palms and soles after certain chemotherapeutic drugs. Docetaxel induced hand-foot syndrome is rare, dose-dependent adverse event. Here in we report a case of Docetaxel induced grade III hand-foot syndrome at low doses (75/m(2)).

Entities:  

Keywords:  Docetaxel; Hand-foot syndrome; low dose

Year:  2015        PMID: 26609297      PMCID: PMC4633196     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  5 in total

1.  Hand-foot syndrome after treatment with docetaxel.

Authors:  Chitra Sivaramamoorthy; Eddy S Thientosapol; Martin H Tattersall
Journal:  Med J Aust       Date:  2009-07-06       Impact factor: 7.738

2.  Prevention of docetaxel-induced erythrodysesthesia with local hypothermia.

Authors:  G C Zimmerman; J H Keeling; M Lowry; J Medina; D D Von Hoff; H A Burris
Journal:  J Natl Cancer Inst       Date:  1994-04-06       Impact factor: 13.506

3.  Docetaxel-induced hand foot syndrome: "No dose is a safe dose".

Authors:  Ankit Jain; Biswajit Dubashi
Journal:  J Pharmacol Pharmacother       Date:  2012-04

4.  Docetaxel-induced Hand and Foot Syndrome in a Patient with Metastatic Breast Carcinoma.

Authors:  Ravichandran Gurumurthi; Ramesh Bv Nimmagadda; Subhashini Mohan
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

5.  Hand-foot syndrome with docetaxel: a five-case series.

Authors:  Mirna H Farhat; Nagi S El-Saghir; Ali I Shamseddine
Journal:  Ann Saudi Med       Date:  2008 Sep-Oct       Impact factor: 1.526

  5 in total
  1 in total

1.  Analysis of drug-induced hand-foot syndrome using a spontaneous reporting system database.

Authors:  Yu Yoshida; Sayaka Sasaoka; Mizuki Tanaka; Kiyoka Matsumoto; Misaki Inoue; Riko Satake; Kazuyo Shimada; Ririka Mukai; Takaaki Suzuki; Mari Iwata; Fumiya Goto; Takayuki Mori; Koki Mori; Tomoaki Yoshimura; Mitsuhiro Nakamura
Journal:  Ther Adv Drug Saf       Date:  2022-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.